Legal Representation
Attorney
Jenifer deWolf Paine
USPTO Deadlines
Next Deadline
96 days remaining
NOA E-Mailed - SOU Required
Due Date
April 15, 2026
Extension Available
Until October 15, 2026
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 15, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 14, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 14, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 14, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 15, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 18, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 18, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 12, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 9, 2025 | ERRR | O | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | Loading... |
| Jan 2, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 31, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 30, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 30, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 1, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 1, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 1, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 24, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 6, 2024 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Aug 6, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 14, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Agents for medical purposes, namely, biotechnologically engineered tissue products in the nature of cells and tissue cell sheets for the treatment of cardiac disease and conditions; biological tissue implants comprising living tissue for medical and cosmetic purposes; biotechnologically engineered tissue products, namely, cells and tissue cell sheets for medical use; regenerative biological tissue sheets for medical purposes; surgical implants comprised of living tissue; transcatheter implants comprised of living tissue; biological material, namely, tissue sheets for the treatment of wounds; biological material, namely, cells and tissue cell sheets for the treatment of damaged skin and tissue; biological tissue grafts; vascular grafts
Class 010
Surgical apparatus; surgical apparatus for medical or veterinary use; medical and surgical apparatus, namely, implantable artificial cardiac valves; medical apparatus for use in percutaneous and endovascular procedures; medical apparatus for use in cardiovascular procedures; medical apparatus for treating cardiovascular disease; cardiac valves for surgical prostheses; prostheses for cardiovascular systems, namely, for the heart and heart valves; artificial cardiac valves for implantation as part of the cardiovascular system; subcutaneous valves comprised of artificial materials for implantation as part of the cardiovascular system; valve implants consisting of artificial materials for implementation as part of the cardiovascular system; medical devices for use in treating cardiac disease; replacement tissue valves being implants comprising artificial and natural, non-living materials for the human heart; catheters
Class 042
Scientific research and development; biomedical research and development
First Use Anywhere:
Aug 11, 2020
First Use in Commerce:
Aug 11, 2020
Additional Information
Design Mark
The mark consists of two crossing arc shapes.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
010
042